GENOMICS USA, INC.
TUCSON, AZ · Founded 2013 · CIK 0001577606 · Medtech · Private
sHLA Protein Chip – a microarray-based immunoassay kit for detecting anti-HLA antibodies in transplant patients
genomics.com →- Grants
- $5.6M
- 5 awards
- Sector median: 1
- Raised
- $837K
- 1 Form D · Jun 2013
- 159 months since last filing
- Contracts
- $3K
- 1 award · Veterans Affairs
- #642 of 4531 in medtech
- Patents
- 10
- 3 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Veterans Affairs · Breast Oncotyping | $3,416 | |
| Private capital raised | Form D · SEC | $837,405 | |
| Federal grant | Department of Health and Human Services · Phase II · sHLA Protein Chip for Anti-HLA Antibody Screening and Monitoring | $1,281,226 | |
| Federal grant | Department of Health and Human Services · Phase II · sHLA Protein Chip for Anti-HLA Antibody Screening and Monitoring | $1,328,325 | |
| Federal grant | Department of Health and Human Services · Phase II · sHLA Protein Chip | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · sHLA Protein Chip | $999,010 | |
| Federal grant | Department of Health and Human Services · Phase II · sHLA Protein Chip | $999,010 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 639 | ID GENOMICS SPC | $4K | $110K |
| 640 | Sofregen Medical Inc. | $4K | $14M |
| 641 | Core Essence Orthopaedics, Inc. | $4K | $7.1M |
| 642 | GENOMICS USA, INC. | $3K | $837K |
| 643 | CATASSAYS | — | — |
| 644 | SYNCRO MEDICAL INNOVATIONS INC | — | $2.3M |
| 645 | APTUS, LLC | — | $2.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- MICHAEL HOGANDirector · Executive Officer
- KRISHNA JAYARAMANDirector · Executive Officer · Promoter
Patents
- Blood Typing Using Dnaapplication
- Methods And Devices Based Upon A Novel Form Of Nucleic Acid Duplex On A Surfacegranted
- Methods For Pcr And Hla Typing Using Unpurified Samplesapplication
- Methods for PCR and HLA Typing Using Unpurified Samplesgranted
- Compositions And Methods For Entrapping Protein On A Surfacegranted
- Blood Typing Using Dnaapplication
- Composition And Methods For Entrapping A Protein On A Surfaceapplication
- Methods For Pcr And Hla Typing Using Raw Bloodapplication
- Methods And Devices Based Upon A Novel Form Of Nucleic Acid Duplex On A Surfaceapplication
- Method For Manufacturing Microarrays Based On The Immobilization Of Porous Substrates On Theamally Modifiable Surfacesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.